Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Supply Disruption — Lupin Pharmaceuticals Inc. (M
Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for Supply Disruption — Lupin Pharmaceuticals Inc. (M is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for; Manufacturer: Lupin
| Drug name | Rifampin Capsules, USP, 150 mg, 30 count HDPE bottles, Rx Only, Manufactured for |
|---|---|
| Manufacturer | Lupin Pharmaceuticals Inc. |
| Recall/Disruption reason | CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity. |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-1343-2022 |
| Initiation date | 20220728 |
| Quantity affected | 7,872/30 count bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →